Most of this catalogue ships as lyophilised powder in a sealed vial. A handful of products ship already in solution. That is not an accident of packaging, and neither format is the better one — they are different trade-offs, and which suits depends on what the material is for.
Why powder is the default
Freeze-drying removes water, and water is the medium almost every degradation pathway needs.
Hydrolysis needs it directly: the peptide bond is broken by water, and no water means no reaction. Oxidation is slowed because dissolved oxygen and mobile metal ions are largely gone. Aggregation, where molecules find each other and stick, needs mobility that a glassy solid does not provide.
The result is a form that tolerates shipping, tolerates a freezer for a long time, and forgives the occasional lapse in handling. That is why a lyophilised vial is the industry default and why most of what is on this site arrives that way.
What a solution gives you instead
The advantage is narrower and worth stating precisely: the concentration is fixed at manufacture and stated on the certificate.
That sounds administrative until you consider what reconstitution actually involves. Someone adds a volume of diluent by eye or by pipette, swirls rather than shakes, waits for it to clear, and records what they intended to add rather than what went in. Any error there propagates through every subsequent calculation, and nothing downstream will reveal it.
A ready-made solution removes that step entirely. The PT-141 liquid spray is 10 mg in 10 mL at 1.0 mg/mL, and that figure was set and verified before the bottle was sealed. Across a run where consistency between sessions matters more than the total life of the bottle, that is a real advantage.
What you give up
Shelf life, and there is no way round it.
Once a peptide is in solution, the reactions that lyophilisation suppressed are available again. Cold storage slows them. Darkness slows the light-driven ones. Neither stops anything.
Three mechanisms account for most of what goes wrong:
Hydrolysis of the backbone, fastest at the extremes of pH and accelerated by heat. Oxidation of the vulnerable residues — methionine, cysteine and tryptophan are the usual candidates — driven by dissolved oxygen and catalysed by trace metals. Aggregation, more of a concern for longer chains, where molecules associate and come out of solution.
A solution product is formulated to slow these down. It is not exempt from them, which is why every one of these bottles carries the same instruction: refrigerate, protect from light.
Which suits which work
The honest version of the comparison:
| Lyophilised powder | Ready-made solution | |
|---|---|---|
| Shelf life | Long | Limited, from manufacture |
| Concentration | Whatever you make it | Fixed and certified |
| Preparation | Reconstitution required | None |
| Variability introduced by you | Real | Removed |
| Suits | Long storage, flexible concentrations | Consistency across a run |
Take the powder when the material will sit for months, when you need concentrations the manufacturer did not choose, or when you want the longest possible window to use it.
Take the solution when the same concentration has to hold across sessions, when reconstitution is a step you would rather not repeat, or when the compound is awkward to get into solution in the first place.
That last case is more common than people expect. Some peptides are slow to clear, and a formulation designed once by someone with the right buffer and the right patience beats the same job done quickly at a bench.
Handling a solution once it arrives
Four things, none of them complicated.
Refrigerate on arrival. Not later that day. The material travelled at ambient temperature and has already spent that budget.
Keep it dark. Light drives oxidation in aromatic residues. The packaging assumes it will be stored closed and shaded, not left out.
Do not freeze it unless the certificate says to. Freeze-thaw cycling is harder on a formulated solution than steady refrigeration, and ice formation concentrates solutes at the boundary in ways that promote aggregation.
Record the date it was opened. Shelf life for a solution runs from manufacture, but the useful figure for your own records is how long it has been in use.
If you are reconstituting powders alongside this, choosing a diluent covers the other half of the decision, and the reconstitution solution is the default for the vials that need it.
Every product referenced here is supplied for laboratory research use only and is not for human or animal use.
References
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharmaceutical Research 2010;27(4):544-575. doi.org/10.1007/s11095-009-0045-6
- Carpenter JF, Pikal MJ, Chang BS, Randolph TW. Rational design of stable lyophilized protein formulations: some practical advice. Pharmaceutical Research 1997;14(8):969-975.
- Niu CH, Chiu YY. FDA perspective on peptide formulation and stability issues. Journal of Pharmaceutical Sciences 1998;87(11):1331-1334. doi.org/10.1021/js9800782
Every product mentioned is sold for laboratory research use only and is not for human or animal use. Nothing on this page describes or recommends use of the material sold here in humans or animals.
